These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 975660)

  • 1. Newer knowledge of the immunology of bone and cartilage.
    Elves MW
    Clin Orthop Relat Res; 1976 Oct; (120):232-59. PubMed ID: 975660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biology of bone graft repair.
    Burchardt H
    Clin Orthop Relat Res; 1983 Apr; (174):28-42. PubMed ID: 6339139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses to osteochondral allografts. Current knowledge and future directions.
    Friedlaender GE
    Clin Orthop Relat Res; 1983 Apr; (174):58-68. PubMed ID: 6339143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of MHC mismatch and freezing on bone graft incorporation: an experimental study in rats.
    Reikerås O; Shegarfi H; Naper C; Reinholt FP; Rolstad B
    J Orthop Res; 2008 Jul; 26(7):925-31. PubMed ID: 18302282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.
    Mathew JM; Garcia-Morales RO; Carreno M; Jin Y; Fuller L; Blomberg B; Cirocco R; Burke GW; Ciancio G; Ricordi C; Esquenazi V; Tzakis AG; Miller J
    Transpl Immunol; 2003; 11(3-4):307-21. PubMed ID: 12967784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of protection from graft-vs-host disease in murine mixed allogeneic chimeras. I. Development of a null cell population suppressive of cell-mediated lympholysis responses and derived from the syngeneic bone marrow component.
    Sykes M; Eisenthal A; Sachs DH
    J Immunol; 1988 May; 140(9):2903-11. PubMed ID: 2966200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological responses to bone soluble proteins in recipients of bone allografts.
    VandeVord PJ; Nasser S; Wooley PH
    J Orthop Res; 2005 Sep; 23(5):1059-64. PubMed ID: 15878650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transplantation immunology of bone and other collagen-based tissues].
    Csönge L
    Orv Hetil; 1994 Jun; 135(25):1347-51. PubMed ID: 8008365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune response to osteochondral allografts in dogs.
    Stevenson S
    J Bone Joint Surg Am; 1987 Apr; 69(4):573-82. PubMed ID: 3553198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of autografts and allografts.
    Goldberg VM; Stevenson S
    Clin Orthop Relat Res; 1987 Dec; (225):7-16. PubMed ID: 3315383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix antigens in allografts. The humoral response.
    Yablon IG; Cooperband S; Covall D
    Clin Orthop Relat Res; 1982 Aug; (168):243-51. PubMed ID: 7105549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological therapy of bone defects: the immunology of bone allo-transplantation.
    Graham SM; Leonidou A; Aslam-Pervez N; Hamza A; Panteliadis P; Heliotis M; Mantalaris A; Tsiridis E
    Expert Opin Biol Ther; 2010 Jun; 10(6):885-901. PubMed ID: 20415596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on bone formation by cartilage reconstructed by isolated epiphyseal chondrocytes, transplanted syngeneically or across known histocompatibility barriers in mice.
    Ksiazek T; Moskalewski S
    Clin Orthop Relat Res; 1983; (172):233-42. PubMed ID: 6821990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?
    Har-Noy M; Slavin S
    Med Hypotheses; 2008; 70(6):1186-92. PubMed ID: 18054441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biology of bone grafts.
    Goldberg VM; Stevenson S
    Semin Arthroplasty; 1993 Apr; 4(2):58-63. PubMed ID: 10148544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone-forming and bone-resorbing cell lines derived from bone marrow in tissue culture.
    Hirano H; Urist MR
    Clin Orthop Relat Res; 1981; (154):234-48. PubMed ID: 7009010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.